BioSyent Launches "menopauseinformation.ca" on World Menopause Day
October 18 2023 - 7:00AM
BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce
the launch of menopauseinformation.ca, a comprehensive online
platform designed to empower peri-menopausal and menopausal women
across Canada.
Menopause is a natural transition that every
woman experiences, and understanding this transition is crucial for
a smoother journey. The menopauseinformation.ca website aims to
provide vital information and resources to help women navigate
through this transition with confidence. By being informed, women
can engage in more effective discussions with their healthcare
providers, leading to better-managed menopause experiences.
This platform offers a wealth of up-to-date
information including expert insights from trusted Canadian
menopause doctors, frequently asked questions, and engaging blogs.
BioSyent is collaborating with these reputable experts to demystify
the biological and emotional changes occurring during menopause,
ensuring women have the knowledge and support they need to make
informed decisions about their health.
“Menopause is a significant phase in a woman’s
life, and we recognize the importance of providing up-to-date and
accessible information to support women in Canada,” said René
Goehrum, President and CEO of BioSyent. “We are committed to
empowering women to take charge of their health by understanding
menopause and engaging with their healthcare providers with
confidence.”
"On behalf of the board of directors of the
Canadian Menopause Society (CMS), we are happy to endorse this
educational initiative on menopause,” said Dr. Wendy Wolfman,
President of the CMS and Dr. Nese Yuksel, President elect of the
CMS. “This series of videos will help inform individuals about
the common symptoms of menopause, long term consequences and
management approaches. The Canadian Menopause Society is committed
to advancing the health of individuals at and beyond the
menopause transition through educational programs
and practice based initiatives.”
For more information or to explore the
menopauseinformation.ca website, please
visit: www.menopauseinformation.caor contact: Email:
info@menopauseinformation.caPhone: 905-206-0013
About BioSyent Inc.
Listed on the TSX Venture Exchange under the
trading symbol “RX”, BioSyent is a profitable growth-oriented
specialty pharmaceutical company focused on in-licensing or
acquiring innovative pharmaceutical and other healthcare products
that have been successfully developed, are safe and effective, and
have a proven track record of improving the lives of patients.
BioSyent supports the healthcare professionals that treat these
patients by marketing its products through its community, specialty
and international business units.
This press release may contain information or
statements that are forward-looking. The contents herein represent
our judgment, as at the release date, and are subject to risks and
uncertainties that may cause actual results or outcomes to be
materially different from the forward-looking information or
statements. Potential risks may include, but are not limited to,
those associated with clinical trials, product development, future
revenue, operations, profitability and obtaining regulatory
approvals.
Neither TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this press release.
Biosyent (TSXV:RX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Biosyent (TSXV:RX)
Historical Stock Chart
From Apr 2023 to Apr 2024